Netherlands· NL-d5816c5d9cb9
Pimafucort, gel, 10 mg/g, 10 mg/g, 3,5 mg/g
A hydrocortisone product containing hydrocortison + natamycine (e 235) + neomycinesulfaat, registered in Netherlands by LEO Pharma A/S. The same ATC class is registered in 5 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Hydrocortisone is registered in 5 of 19 countries.
Countries holding a registration under ATC D07XA01 (hydrocortisone), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 2 of them publish a price we can compare per daily dose
Hydrocortisone · ATC D07XA01
5 / 19 countries
- Canada
- Finlandprice
- Ireland
- Netherlands
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HYDROCORTISON + NATAMYCINE (E 235) + NEOMYCINESULFAAT
- Manufacturer
- LEO Pharma A/S
- Country
- Netherlands (NL)
- ATC code
- D07XA01
- ATC class
- Hydrocortisone
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id03400
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for hydrocortisone.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydrocortisone · interactions on record
55 records
Same medicine, other countries
Hydrocortisone in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Finland · Pimafucort
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0da76295-c0d4-4f89-9a52-f17d7a5272be GET /v1/drugs/0da76295-c0d4-4f89-9a52-f17d7a5272be?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gel",
"route": "Cutaan gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h03400_smpc.pdf",
"strength": null,
"atc_label": "Hydrocortisone",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg03400",
"excipients": [
"PARAFFINE, VLOEIBAAR (E905)",
"PLASTIBASE {MIXTURE OF 2 INGREDIENTS} (RI)",
"POLYETHYLEEN"
],
"substances": [
"HYDROCORTISON",
"NATAMYCINE (E 235)",
"NEOMYCINESULFAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h03400.pdf",
"authorised_at": "1970/11/25",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "03400",
"additional_monitoring": "N"
}See everything about hydrocortisone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.